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We report about West Nile virus (WNV) infections in 
a symptomatic traveller returning from Israel and in 
her asymptomatic travel companion. Knowledge of the 
current epidemiological situation in Israel from where 
WNV cases were reported recently enabled a rapid 
diagnosis. The described cases serve as a reminder 
for physicians to consider WNV in the diagnosis of 
patients returning from areas with potential circula-
tion of the virus.
At the end of July 2010, a Dutch woman in her early 
thirties presented to our first aid department with 
fever, retro-orbital headache and a macular rash. The 
day before she had returned from a 10-day holiday to 
Israel where she noticed several mosquito bites during 
a camping trip at the Sea of Galilee. There was no his-
tory of tick bites. Five days before presentation, she 
had suddenly fallen ill with extreme fatigue, myalgia, 
fever and an increasingly severe headache. Movement 
of the eyes had been painful. The next day she had 
developed a burning sensation of the skin that was fol-
lowed by a skin eruption. The rash started on the trunk 
and spread to arms and legs. 
Upon presentation in the first aid department she 
did not appear ill. Body temperature was 36.4°C. 
There was a generalised macular rash, sparing hands 
and feet, and no petechiae or eschars were present. 
Neurological examination revealed no abnormalities. 
Potential infection with West-Nile virus was suspected 
because of the clinical picture and recent reports of 
West Nile virus cases in Israel [1].
Laboratory examination showed a leukopenia of 
1.8x109/L with a predominance of large granular lym-
phocytes; thrombocyte count was 92x109/L. Infection 
with Epstein Barr virus, cytomegalovirus, dengue 
virus, enterovirus and parechovirus was excluded by 
serology and antigen test or PCR. A lumbar punction 
was not performed due to missing neurological symp-
toms. West Nile virus RNA could not be detected in the 
EDTA plasma sample taken on day five after onset of 
disease by a TaqMan reverse transcriptase-PCR assay, 
using a probe for the WN3’NC [2]. However, in a second 
blood sample obtained fifteen days later, seroconver-
sion for both serum IgG and IgM antibodies against 
West Nile virus was detected with an indirect quali-
tative enzyme-linked immunosorbent assay (ELISA) 
(Focus Diagnostics, Cypress, California). This assay 
uses antibody capture technique for the detection of 
IgM antibodies. 
Once the diagnosis was confirmed, serology was per-
formed in the patient’s travel companion who reported 
having had similar complaints, but who had already 
recovered by the time he returned to the Netherlands. 
The laboratory results showed that he was seroposi-
tive for WNV IgG and IgM. Recovery was uneventful in 
both patients.
West-Nile virus is endemic in Israel. The largest recent 
outbreak in humans in Israel occurred in the year 2000 
with more than 400 reported cases [3]. Recently, 12 
cases of West Nile fever have been reported, centered 
around the Tel Aviv area [1]. Culex perexiguus, Cx. pipi-
ens, and Aedes caspius are the vectors of West Nile 
virus in Israel where most cases of West Nile fever 
occur between August and October. The seasonal 
occurrence of human cases reaches a peak one month 
after the mosquito peak [4]. 
Measures to avoid mosquito bites such as wearing pro-
tective clothes and using repellents are recommended 
during the whole transmission season and this case 
report serves as a reminder to physicians to consider 
West Nile fever in patients with fever returning from 
Israel.
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